Under the terms of the agreement, Alnylam will provide $30 million in upfront consideration, including cash and an equity ...
On Sunday, Dr. Brian Wolpin of the Dana-Farber Cancer Institute presented data on pancreatic cancer that is moving the field ...
FDA’s draft guidance allows sponsors to leverage public and platform knowledge for CMC, nonclinical, and clinical support of ...
RNA exon editing enables replacement of multiple entire exons at kilobase scale, potentially addressing large genes and high ...
Eli Lilly moves to deny 340B discounts to hospitals refusing to submit claims data under its documentation policy, escalating ...
The results of the survey revealed that the growing direct-to-patient approach is having a significant impact on how ...
HHS Secretary Kennedy has also highlighted his concerns with DTC prescription drug advertisements. At the time of the ...
A wave of expiries will hit high-value assets, including Keytruda, Eliquis, Ibrance, and Trulicity, amplifying revenue ...
A trio of deals from Eli Lilly, Servier, and Avenzo highlights continued industry investment in rare diseases and oncology, ...
FDA approves Shionogi’s Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy, marking a major milestone for Covid-19 prevention treatments. FDA has approved Shionogi’s Xocova (ensitrelvir) ...
FDA approves Gilead’s Hepcludex as the first treatment for chronic hepatitis delta virus in the U.S., marking a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results